Prostate Cancer Patients With Detectable PSA Following Prostatectomy
2 clinical trials · Condition
◉ Watch Prostate Cancer Patients With Detectable PSA Following Prostatectomy
| Record | Firm | Date |
|---|---|---|
| 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer (NCT06970847) | Clarity Pharmaceuticals Ltd | 2025-05-16 |
| Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy (NCT01548807) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
Track Prostate Cancer Patients With Detectable PSA Following Prostatectomy automatically
Every clearance here is in the API, with alerts when new ones post.